Griese M, Zarbock R, Costabel U, Hildebrandt J, Theegarten D, Albert M, et al. GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders. BMC Pulm Med. 2015;15:87 pubmed publisher
..Treatment with whole lung lavages as well as stem cell transplant may be successful. ..
Stintzing S, Miller Phillips L, Modest D, Fischer von Weikersthal L, Decker T, Kiani A, et al. Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study. Eur J Cancer. 2017;79:50-60 pubmed publisher
..ETS represents an early parameter associated with the benefit from anti-EGFR, while this was not the case with vascular endothelial growth factor A blockade. ..
Holch J, Metzeler K, Jung A, Riedmann K, Jost P, Weichert W, et al. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?. Eur J Cancer. 2017;82:72-79 pubmed publisher
..On this basis, it will review the clinical evidence of this approach and summarise recommendations for the ongoing evaluation of UGT as the next step in oncological decision-making. ..